Total Payments
$1,997
2024 Payments
$739.24
Companies
12
Transactions
98
Medicare Patients
1,130
Medicare Billing
$327,544
Payment Breakdown by Category
Food & Beverage$1,982 (99.2%)
Other$15.00 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,982 | 97 | 99.2% |
| Honoraria | $15.00 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $682.20 | 39 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $346.41 | 20 | $0 (2024) |
| Boston Scientific Corporation | $286.50 | 5 | $0 (2024) |
| Lundbeck LLC | $178.30 | 8 | $0 (2024) |
| PROTEGA PHARMACEUTIALS INC | $171.12 | 8 | $0 (2023) |
| Scilex Pharmaceuticals Inc. | $113.34 | 7 | $0 (2022) |
| IBSA Pharma Inc. | $109.68 | 5 | $0 (2024) |
| ABBVIE INC. | $36.25 | 2 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $25.27 | 1 | $0 (2024) |
| PFIZER INC. | $20.14 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $739.24 | 29 | Boston Scientific Corporation ($270.14) |
| 2023 | $346.98 | 18 | Collegium Pharmaceutical, Inc. ($129.45) |
| 2022 | $546.38 | 29 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($246.71) |
| 2021 | $364.31 | 22 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($155.02) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $32.20 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Gastroenterology | ||||||
| 10/25/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $163.68 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.39 | General |
| Category: NEUROLOGY | ||||||
| 08/26/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $25.27 | General |
| 08/13/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $21.01 | General |
| Category: Endocrinology | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Gastroenterology | ||||||
| 08/01/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/24/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Gastroenterology | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Gastroenterology | ||||||
| 06/24/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.60 | General |
| Category: Opioid Analgesic | ||||||
| 05/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Gastroenterology | ||||||
| 05/21/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.76 | General |
| Category: Opioid Analgesic | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Gastroenterology | ||||||
| 04/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Gastroenterology | ||||||
| 04/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.77 | General |
| Category: Opioid Analgesic | ||||||
| 04/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Gastroenterology | ||||||
| 04/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: NEUROLOGY | ||||||
| 03/28/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Opioid Analgesic | ||||||
| 02/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Gastroenterology | ||||||
| 02/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.61 | General |
| Category: Opioid Analgesic | ||||||
| 02/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.36 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 214 | 982 | $291,151 | $70,972 |
| 2022 | 4 | 234 | 1,101 | $336,048 | $80,676 |
| 2021 | 3 | 283 | 1,234 | $379,900 | $90,825 |
| 2020 | 6 | 399 | 1,311 | $420,294 | $85,072 |
Total Patients
1,130
Total Services
4,628
Medicare Billing
$327,544
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 747 | $231,025 | $53,710 | 23.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 77 | 200 | $36,792 | $12,180 | 33.1% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 12 | 14 | $12,521 | $2,727 | 21.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 17 | 21 | $10,814 | $2,355 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 849 | $259,773 | $62,115 | 23.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 87 | 215 | $51,104 | $12,973 | 25.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 13 | 17 | $15,204 | $3,329 | 21.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 15 | 20 | $9,967 | $2,259 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 172 | 973 | $295,520 | $73,195 | 24.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 100 | 247 | $71,860 | $15,025 | 20.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 11 | 14 | $12,521 | $2,605 | 20.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 196 | 938 | $284,688 | $56,653 | 19.9% |
| 80307 | Testing for presence of drug | Office | 2020 | 120 | 247 | $71,860 | $15,031 | 20.9% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 21 | 28 | $25,041 | $5,525 | 22.1% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 30 | 39 | $20,083 | $4,332 | 21.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 12 | 13 | $9,166 | $2,017 | 22.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 46 | $9,456 | $1,514 | 16.0% |
About Amanda Larson
Amanda Larson is a Registered Nurse healthcare provider based in Mt Juliet, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1053729327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Larson has received a total of $1,997 in payments from pharmaceutical and medical device companies, with $739.24 received in 2024. These payments were reported across 98 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,982).
As a Medicare-enrolled provider, Larson has provided services to 1,130 Medicare beneficiaries, totaling 4,628 services with total Medicare billing of $327,544. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Family, Nurse Practitioner
- Location Mt Juliet, TN
- Active Since 07/30/2014
- Last Updated 11/16/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1053729327
Products in Payments
- RELISTOR (Drug) $682.20
- WaveWriter Alpha Prime 16 (Device) $286.50
- XTAMPZA (Drug) $243.93
- VYEPTI (Biological) $178.30
- Roxybond (Drug) $131.95
- Belbuca (Drug) $102.48
- Tirosint (Drug) $73.57
- ZTLido (Drug) $62.03
- ROXYBOND (Drug) $39.17
- Licart (Drug) $36.11
- QULIPTA (Drug) $19.45
- UBRELVY (Drug) $16.80
- Movantik (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Mt Juliet
Mrs. Bailey Mcneese, Msn, Aprn, Np-C, MSN, APRN, NP-C
Registered Nurse — Payments: $720.74
Registered Nurse $720.74
Rachel Walker, Whnp-Bc, WHNP-BC
Registered Nurse — Payments: $310.28
Registered Nurse $310.28
Megan Steinmetz, Rn, RN
Registered Nurse — Payments: $97.32
Registered Nurse $97.32
Khang Nguyen, Srna, Rn, SRNA, RN
Registered Nurse
Registered Nurse
Shirley Treutel, Bsn, BSN
Registered Nurse
Registered Nurse
Jonathan Velting, Rn, RN
Registered Nurse
Registered Nurse